Novan Depreciation & Amortization 2011-2026 | NOVN

Annual Depreciation & Amortization Novan

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.18 M	344 K	1.17 M	2.03 M	1.66 M	1.42 M	757 K	631 K	462 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.03 M	344 K	1.07 M

Quarterly Depreciation & Amortization Novan

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
410 K	-	468 K	247 K	97 K	-	104 K	81 K	57 K	-	120 K	492 K	495 K	-	510 K	518 K	503 K	-	425 K	408 K	401 K	-	391 K	340 K	299 K	-	187 K	201 K	186 K	-	452 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
518 K	57 K	321 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	762 M	$ 212.08	0.45 %	$ 375 B	USA
AbCellera Biologics ABCL	18.4 M	$ 3.29	-1.94 %	$ 983 M	Canada
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	16 M	$ 12.29	-11.96 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 1.08	-1.38 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Summit Therapeutics SMMT	146 K	$ 16.55	-4.11 %	$ 12.4 B	Britain
Alnylam Pharmaceuticals ALNY	55.7 M	$ 319.85	-2.53 %	$ 41.9 B	USA
Arbutus Biopharma Corporation ABUS	363 K	$ 4.34	-2.47 %	$ 832 M	Canada
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Fusion Pharmaceuticals FUSN	1.34 M	-	-	$ 1.41 B	Canada